Stockreport

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND enabling studies Ad Hoc Announcement Pursuant to Art. 53 LR [Read more]